![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1559457
¼¼°èÀÇ µÎ°³¾Ç ¾È¸é °íÁ¤(CMF) ÀåÄ¡ ½ÃÀå : ½ÃÀå ÀλçÀÌÆ®, °æÀï ±¸µµ, ½ÃÀå ¿¹Ãø(-2030³â)Cranio Maxillofacial Fixation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
¼¼°èÀÇ µÎ°³¾Ç ¾È¸é °íÁ¤(CMF) ÀåÄ¡ ½ÃÀå ±Ô¸ð´Â 2023³â¿¡ 17¾ï 6,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í 2030³â±îÁö 23¾ï 6,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ¿¹Ãø ±â°£ µ¿¾È º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 5.05%ÀÇ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. ½ÃÀåÀº ÀÚµ¿Â÷ »ç°í³ª ½ºÆ÷Ã÷¿¡ ÀÇÇÑ ¿Ü»ó¼º ³ú ¼Õ»óÀÇ ³ôÀº ¹ß»ý·ü, »ó¾Ç °ñÀýÀÇ »ó´çÇÑ À¯º´·ü, ¾È¸é ¿Ü»ó »ç·ÊÀÇ º¹ÀâÈ, Ä¿½ºÅ͸¶ÀÌÁî ÀÓÇöõÆ®¿¡ ÀÌ¿ëÇÏ´Â 3D ÇÁ¸°ÆÃ°ú °°Àº ÷´Ü ±â¼úÀÇ ÅëÇÕ µî¿¡ ÀÇÇØ ¿¹Ãø ±â°£ µ¿¾È Å« ¼ºÀåÀ» ³ªÅ¸³»°í ÀÖ½À´Ï´Ù.
µÎ°³¾Ç ¾È¸é °íÁ¤(CMF) ÀåÄ¡ ½ÃÀå ¿ªÇÐ
International Brain Injury Association(2024³â)¿¡ µû¸£¸é À¯·´ ¿¬ÇÕ(EU) ³»¿¡¼´Â ³ú ¼Õ»óÀ¸·Î ¿¬°£ ¾à 100¸¸ ¸íÀÌ ÀÔ¿øÇϰí ÀÖ½À´Ï´Ù. ÀÌ Áß ÀÚµ¿Â÷ »ç°í´Â ¿Ü»ó¼º ³ú¼Õ»ó(TBI)ÀÇ 50%¸¦ Â÷ÁöÇÕ´Ï´Ù. °Ô´Ù°¡ ½ºÆ÷Ã÷¿Í °ü·ÃµÈ ³ú¼Õ»óµµ ÀÌ ¼öÄ¡¿¡ Å©°Ô ±â¿©Çϰí ÀÖÀ¸¸ç, ¸Å³â 30¸¸ ¸íÀÌ ºÎ»óÇϰí ÀÖ´Â °ÍÀ¸·Î ÃßÁ¤µÇ°í ÀÖ½À´Ï´Ù. °Ü¿ï ½ºÆ÷Ã÷, ƯÈ÷ ½ºÅ°¿Í ¾ÆÀ̽º ½ºÄÉÀÌÆÃÀº ÀÌ·¯ÇÑ ³ú ¼Õ»ó Áß ¾à 20,000°Ç°ú °ü·ÃÀÌ ÀÖ½À´Ï´Ù. ÀÌ¿Í °°ÀÌ ÀÚµ¿Â÷ »ç°í³ª ½ºÆ÷Ã÷ °ü·Ã Ȱµ¿¿¡ ÀÇÇÑ ³ú ¼Õ»óÀÇ ¹ß»ý·üÀÌ ³ô±â ¶§¹®¿¡ È¿°úÀûÀÎ Ä¡·á ¼Ö·ç¼ÇÀÇ Çʿ伺ÀÌ ³ô¾ÆÁö°í ÀÖÀ¸¸ç, ÀÌ·¯ÇÑ ¼Õ»ó¿¡ ´ëóÇÏ´Â µÎ°³¾Ç ¾È¸é °íÁ¤(CMF) ÀåÄ¡ ¼ö¿ä °¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.
National Institute of Health(2023³â)ÀÇ µ¥ÀÌÅÍ¿¡ µû¸£¸é, ½ºÆ÷Ã÷ ºÎ»óÀº »ó¾Ç °ñÀýÀÇ »ó´ç ºÎºÐÀ» Â÷ÁöÇϰí ÀÖÀ¸¸ç, ±× ¹üÀ§´Â 6%-33%ÀÔ´Ï´Ù. ´ºÁú·£µå¿¡¼ ½Ç½ÃµÈ ¾È¸é °ñÀý ȯÀÚ 2¸¸ 5,000¸íÀ» ´ë»óÀ¸·Î ÇÑ ¿¬±¸¿¡ µû¸£¸é, ¾È¸é Áß¾ÓºÎÀÇ °ñÀýÀÌ 63.5%·Î »ó´çÈ÷ ¸¹¾Ò°í, ¾È¸é »óºÎÀÇ °ñÀýÀº ºÒ°ú 3.3%¿´½À´Ï´Ù. ¾È¸é ¿Ü»ó ȯÀÚ 93¸íÀÇ ¿¬±¸¿¡¼´Â 2019³âÀÇ µ¥ÀÌÅÍ¿¡ ±Ù°ÅÇÏ¿© ¾È¿Í ÇϰøÀÌ 56.9%ÀÇ »ç·Ê·Î ¿µÇâÀ» ¹Þ°í ¾È°úÀúÀÇ º¯À§°¡ 86%ÀÇ »ç·Ê·Î ÀÎÁ¤µÇ¾ú½À´Ï´Ù. µû¶ó¼ ½ºÆ÷Ã÷ ºÎ»óÀ¸·Î ÀÎÇÑ »ó¾Ç °ñÀýÀÇ À¯º´·ü, Á߾ȸéÀÇ ½É°¢ÇÑ Ä§½À, ¾È¿Í Çϰø ¹× ¾È¿ÍÀú º¯À§ÀÇ ³ôÀº ºñÀ²Àº µÎ°³¾Ç ¾È¸é °íÁ¤(CMF) ÀåÄ¡¿¡ ´ëÇÑ ¼ö¿ä¸¦ °ÇÏ°Ô º¸¿©ÁÝ´Ï´Ù.
¶ÇÇÑ ¸ÂÃãÇü ȯÀÚ Àü¿ë ÀÓÇöõÆ® °³¹ß¿¡ »ç¿ëµÇ´Â 3D ÇÁ¸°ÆÃ°ú °°Àº ÷´Ü ±â¼ú ÅëÇÕ°ú ´ë»ó »ç¶÷µé »çÀÌÀÇ ³ôÀº ¼±È£µµ´Â µÎ°³¾Ç ¾È¸é °íÁ¤(CMF) ÀåÄ¡ ½ÃÀåÀ» ¼ºÀå½Ãŵ´Ï´Ù. ¶ó°í ¿¹ÃøµË´Ï´Ù. ¿¹¸¦ µé¾î, 2021³â 7¿ù, Lucid Implants´Â °í±Þ 3D ÇÁ¸°ÆÃ ±â¼ú°ú °¡»ó ¼ö¼ú °èȹÀ» ÅëÇØ ȯÀÚ Æ¯À¯ÀÇ ¾È¸é ÇØºÎÇÐÀû ±¸Á¶¸¦ ¿°µÎ¿¡ µÐ PEEK ±â¹ÝÀÇ ¸ÂÃãÇü ÀÓÇöõÆ®¸¦ »ý»êÇÏ´Â Àεµ ÃÖÃÊÀÇ ±â¾÷ÀÌ µÇ°í ÀÖ½À´Ï´Ù.
µû¶ó¼ 2024³âºÎÅÍ 2030³â±îÁöÀÇ ¿¹Ãø ±â°£¿¡ À§ÀÇ ¸ðµç ¿äÀÎÀÌ »óÈ£ ÀÛ¿ëÇÏ¿© µÎ°³¾Ç ¾È¸é °íÁ¤(CMF) ÀåÄ¡ ½ÃÀåÀ» °ßÀÎÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
±×·¯³ª ±ÁÈû, ´À½¼ÇÔ ¹× ¼Õ»óÀ» Æ÷ÇÔÇÑ ÀÓÇöõÆ®ÀÇ ±â°èÀû °íÀå°ú ¾Ð·Â ¹× Ç÷Á¾À¸·Î ÀÎÇÑ ÀϽÃÀû ¶Ç´Â ¸¸¼º ½Å°æ ¼Õ»óÀº µÎ°³¾Ç ¾È¸é °íÁ¤(CMF) ÀåÄ¡ ½ÃÀåÀÇ ¼ºÀåÀ» ¾ïÁ¦ÇÒ ¼ö ÀÖ½À´Ï´Ù.
µÎ°³¾Ç ¾È¸é °íÁ¤(CMF) ÀåÄ¡ ½ÃÀåÀÇ ºÎ¹® ºÐ¼®
µÎ°³¾Ç ¾È¸é °íÁ¤(CMF) ÀåÄ¡ ½ÃÀåÀÇ ÀÀ¿ë ºÐ¾ß¿¡¼´Â ½Å°æ¿Ü°ú ¼ö¼ú Ä«Å×°í¸®°¡ 2023³â ÃÖ´ë ½ÃÀå ¼öÀÍ Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¹üÁÖÀÇ ±Þ¼ºÀåÀº º¹ÀâÇÑ µÎ°³ º¹±¸ ¹× Àç°ÇÀÌ ÀÚÁÖ ÇÊ¿äÇÑ ½Å°æ Áúȯ°ú ¿Ü»ó¼º ³ú ¼Õ»óÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇÑ °ÍÀÔ´Ï´Ù. ³ú½Å°æ ¼ö¼úÀº Á¾Á¾ µÎ°³ ¾È¸é ±¸Á¶¿¡ º¹ÀâÇÏ°í ½É°¢ÇÑ °³ÀÔÀ» ¼ö¹ÝÇÏ¸ç ¾ÈÁ¤ÀûÀ̰í Á¤È®ÇÑ °á°ú¸¦ º¸ÀåÇÏ´Â °íÁ¤ ÀåÄ¡¸¦ »ç¿ëÇØ¾ßÇÕ´Ï´Ù.
¿µ»óó¸®ÀÇ °È³ª Àúħ½À Á¢±Ù µî ½Å°æ¿Ü°ú ¼ö¼úÀÇ ±â¹ý°ú ±â¼úÀÇ Áøº¸°¡ ÀÌ ºÎ¹®ÀÇ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀåÄ¡´Â ±¸Á¶Àû Áö¿øÀ» Á¦°øÇÏ°í ½Å°æ ¿Ü°ú ¼ö¼úÀ»¹Þ´Â ȯÀÚÀÇ ÃÖÀû ȸº¹À» ÃËÁøÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. ½Å°æ ¼ö¼úÀÌ ÁøÈ¿Í È®ÀåÀ» °è¼ÓÇÏ´Â µ¿¾È °íǰÁúÀÇ CMF °íÁ¤ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ÀÇÁ¸µµ´Â ¼öÀÍ Á¡À¯À²À» ´õ¿í ³ôÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
µû¶ó¼ ¾Õ¼ ¾ð±ÞÇÑ ¸ðµç ¿äÀεé·Î ÀÎÇØ ½Å°æ¿Ü°ú ¼ö¼ú ¹üÁÖ´Â »ó´çÇÑ ¼ºÀåÀ» º¸ÀÌ¸ç ±Ã±ØÀûÀ¸·Î 2024-2030³âÀÇ ¿¹Ãø ±â°£¿¡ µÎ°³¾Ç ¾È¸é °íÁ¤(CMF) ÀåÄ¡ ½ÃÀå ÀüüÀÇ ¼ºÀå¿¡ ±â¿©ÇÒ Àü¸ÁÀÔ´Ï´Ù.
º» º¸°í¼´Â ¼¼°èÀÇ µÎ°³¾Ç ¾È¸é °íÁ¤(CMF) ÀåÄ¡ ½ÃÀå¿¡ ´ëÇÑ Á¶»ç ºÐ¼®À» ÅëÇØ °¢ Áö¿ª ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, Áö³ 3³â°£ÀÇ Á¦Ç°/±â¼ú °³¹ß, °¢ ºÎ¹®ÀÇ ½ÇÀû°ú Àü¸Á µîÀÇ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù.
Cranio Maxillofacial Fixation (CMF) Devices Market by Product Type (CMF Plate And Screw Fixation Devices, Cranial Flap Fixation Devices, CMF Distraction Devices, Temporomandibular Joint Replacement Devices, and Bone Graft Substitute), Material (Metals & Alloys, Bioabsorbable, Ceramics, and Others), Application (Neurosurgery, Orthognathic Surgery, Plastic Surgery, and Others), End-User (Hospitals, Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a substantial CAGR forecast till 2030 owing to the increasing incidence of traumatic brain injuries, facial fractures, and the rising research and product development activities across the globe
The cranio maxillofacial fixation devices market was valued at USD 1.76 billion in 2023, growing at a CAGR of 5.05% during the forecast period from 2024 to 2030 to reach USD 2.36 billion by 2030. The cranio maxillofacial fixation devices market is experiencing significant growth owing to the high incidence of traumatic brain injuries from motor vehicle accidents, and sports, the considerable prevalence of maxillary fractures, and the increasing complexity of facial trauma cases, the integration of advanced technologies like 3D printing for customized implants, among others which is expected to drive the cranio maxillofacial fixation devices market during the forecast period from 2024 to 2030.
Cranio Maxillofacial Fixation (CMF) Devices Market Dynamics:
According to International Brain Injury Association (2024), brain injuries result in approximately one million hospital admissions annually within the European Union. Among these, motor vehicle crashes are responsible for 50% of traumatic brain injuries (TBIs). Additionally, sports-related brain injuries contribute significantly to this figure, with an estimated 300,000 injuries occurring each year. Winter sports, particularly skiing and ice-skating, are linked to around 20,000 of these brain injuries. Thus high incidence of brain injuries from motor vehicle crashes and sports-related activities underscores a growing need for effective treatment solutions, highlighting the demand for cranio maxillofacial fixation (CMF) devices to address these injuries.
According to data from the National Institute of Health (2023), sporting injuries account for a significant portion of maxillary fractures, ranging from 6% to 33%. A study in New Zealand of 25,000 patients with facial fractures found that a substantial portion involved the midface, at 63.5%, while only 3.3% involved the upper third of the face. A review of 93 patients with facial trauma revealed that the infraorbital foramen was affected in 56.9% of cases, and displacement of the orbital floor was present in 86% of cases based on data from 2019. Thus, the prevalence of maxillary fractures due to sporting injuries, the significant involvement of the midface, and the high rates of infraorbital foramen and orbital floor displacement highlight the demand for Cranio Maxillofacial Fixation (CMF) devices.
Furthermore, integrating advanced technology such as 3-D printing for developing customized and patient-specific implants and their high preference among the target population is also projected to grow the cranio maxillofacial fixation devices market. For instance, in July 2021, Lucid Implants became the first Indian company to produce Polyether ether ketone (PEEK) based customized implants keeping patients' unique facial anatomy in mind with advanced 3D printing technologies and virtual surgical planning.
Hence, the interplay of all the above mentioned factors are expected to drive the market of cranio maxillofacial fixation (CMF) devices market during the given forecast period from 2024 to 2030.
However, mechanical failure of the implant, including bending, loosening or breakage and temporary or chronic neural damage resulting from pressure or hematomata may restrain the growth of the cranio maxillofacial fixation (CMF) devices market.
Cranio Maxillofacial Fixation (CMF) Devices Market Segment Analysis:
Cranio Maxillofacial Fixation (CMF) Devices Market by Product Type (CMF Plate And Screw Fixation Devices, Cranial Flap Fixation Devices, CMF Distraction Devices, Temporomandibular Joint Replacement Devices, and Bone Graft Substitute), Material (Metals & Alloys, Bioabsorbable, Ceramics, and Others), Application (Neurosurgery, Orthognathic Surgery, Plastic Surgery, and Others), End-User (Hospitals, Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the application segment of cranio maxillofacial fixation (CMF) device market, the neurosurgery category is predicted to account for the largest market revenue share in 2023. The rapid growth of this category can be attributed due the increasing prevalence of neurological disorders and traumatic brain injuries, which frequently require complex cranial repairs and reconstructions. Neurosurgical procedures often involve intricate and critical interventions on the craniofacial structure, necessitating the use of fixation devices to ensure stable and precise outcomes.
The advancements in neurosurgical techniques and technology, including enhanced imaging and minimally invasive approaches, have contributed to the growth of this segment. These devices play a crucial role in providing structural support and facilitating optimal recovery in neurosurgical patients. As neurosurgery continues to evolve and expand, the reliance on high-quality CMF fixation solutions is expected to further bolster its revenue share.
Therefore, due to all the aforementioned factors, the neurosurgery category is likely to witness considerable growth, eventually contributing to growth of the overall cranio maxillofacial fixation (CMF) device market during the forecast period from 2024 to 2030.
North America is expected to dominate the overall cranio maxillofacial fixation (CMF) device market:
Among all the regions, North America is expected to amass the largest share of the cranio maxillofacial fixation (CMF) devices market. This can be ascribed to the rising incidence of facial cosmetic procedures and traumatic brain injuries, advancements in product development & regulatory approvals, and the significant contributions of key market players in the region. The combination of these factors is expected to drive the continued expansion and innovation in the cranio maxillofacial fixation (CMF) device market from 2024 to 2030.
As per data from the American Society of Plastic Surgeons for 2024, there were 1,575,244 facial cosmetic surgery procedures performed in the United States in 2023. This represents a notable increase from the 1,498,361 procedures conducted in 2022, reflecting a growth rate of approximately 5%. This upward trend highlights the growing demand for facial cosmetic procedures, underscoring the expanding market of cranio maxillofacial fixation (CMF) device.
According to the data provided by the Centre for Disease Control and Prevention (2024), in 2021, there were more than 586 traumatic brain injury-related hospitalizations per day in the US. Traumatic brain injuries, caused by head trauma from accidents, falls, or sports injuries, require prompt and accurate diagnosis to assess the extent of brain damage and guide treatment decisions. These conditions often lead to fractures that require surgical intervention and stabilization to ensure proper healing.
Increasing product developmental activities by the regulatory body like product clearances in the region also pushes forward the revenue share of these devices. For instance, in December 2023, RevBio, Inc. announced approval from the U.S. Food and Drug Administration to initiate a pilot clinical trial involving 20 patients. This trial will evaluate the safety and efficacy of TETRANITE, the company's innovative bone adhesive biomaterial, for the immediate stabilization and fixation of cranial flaps following craniotomy procedures related to brain surgery.
The presence of key market players in the region is significantly bolstering the market for Cranio Maxillofacial Fixation (CMF) devices. Major companies like Stryker, Zimmer Biomet, and Medtronic have established strong footholds in the region, driving innovation and market growth. For example Zimmer Biomet's commitment to developing cutting-edge CMF devices, such as their comprehensive range of fixation plates and screws, has further strengthened their market position. The extensive research and development activities, combined with a robust distribution network, enable these players to deliver high-quality, technologically advanced products to a wide end-user base.
Thus, all the factors mentioned above promote a conducive environment for the cranio maxillofacial fixation (CMF) devices market during the forecast period from 2024 to 2030.
Cranio Maxillofacial Fixation (CMF) Devices Market key players:
Some of the key market players operating in the cranio maxillofacial fixation devices market include Zimmer Biomet, Stryker Corporation, Medtronic, Johnson & Johnson Services, Inc, Advin Health Care, LUCID Implants, Auxein Medical, KLS Martin Group, Medartis AG, Integra LifeSciences, Aesculap, Inc, OsteoMed, Inion, JEIL MEDICAL CORPORATION, and others.
Recent Developmental Activities in the Cranio Maxillofacial Fixation (CMF) Devices Market:
Key Takeaways from the Cranio Maxillofacial Fixation (CMF) Devices Market Report Study
Target audience who can be benefited from this Cranio Maxillofacial Fixation (CMF) Devices Market Report Study
Frequently Asked Questions for the Cranio Maxillofacial Fixation (CMF) Devices Market:
Cranio maxillofacial fixation (CMF) devices are used to rectify the facial deformity or skull fracture to restore proper function. The CMF devices include plate and screw systems, distractors, bone grafts, and others.
The cranio maxillofacial fixation devices market was valued at USD 1.76 billion in 2023, growing at a CAGR of 5.05% during the forecast period from 2024 to 2030 to reach USD 2.36 billion by 2030.
The cranio maxillofacial fixation devices market is experiencing significant growth owing to the high incidence of traumatic brain injuries from motor vehicle accidents and sports, the significant prevalence of maxillary fractures, and the increasing complexity of facial trauma cases, the integration of advanced technologies like 3D printing for customized implants further supports this growth, and among others which is expected to drive the cranio maxillofacial fixation devices market during the forecast period from 2024 to 2030.
Some of the key market players operating in the cranio maxillofacial fixation devices market include Zimmer Biomet, Stryker Corporation, Medtronic, Johnson & Johnson Services, Inc, Advin Health Care, LUCID Implants, Auxein Medical, KLS Martin Group, Medartis AG, Integra LifeSciences, Aesculap, Inc, OsteoMed, Inion, JEIL MEDICAL CORPORATION, and others.
Among all the regions, North America is estimated to hold a significant revenue share in the cranio maxillofacial fixation devices market. This can be ascribed to the rising incidence of facial cosmetic procedures and traumatic brain injuries, advancements in product development & regulatory approvals, and the significant contributions of key market players in the region. The combination of these factors is expected to drive the continued expansion and innovation in the cranio maxillofacial fixation (CMF) device market from 2024 to 2030.